DCGI nod to AstraZeneca India breast cancer drug Lynparza Ruchika Sharma20 Aug 2022 11:49 AM ISTEarly breast cancer is defined as the cancer confined to the breast with or without regional lymph node involvement and the absence of distant...
DCGI Chief Dr V G Somani tenure extended by 3 months Ruchika Sharma17 Aug 2022 5:00 PM ISTNew Delhi: The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued...
DCGI classifies 60 medical devices related to rehabilitation Roshni Dhar16 Aug 2022 6:30 PM ISTIn order to regulate the safety, quality, and performance of medical devices, the Drug Controller General (India), Directorate General of Health...
Health Bulletin 16/August/2022 Roshni Dhar16 Aug 2022 5:30 PM ISTHere are the top health stories for the day:NMC approval for medical colleges in wanaparthy, sangareddy with 150 MBBS seats eachThe total number of...
Risk classification: DCGI classifies 60 medical devices related to rehabilitation Dr. Divya Colin14 Aug 2022 1:30 PM ISTNew Delhi: In order to regulate the safety, quality, and performance of medical devices, the Drug Controller General (India), Directorate General of...
Serum Institute to supply 1 crore qHPV vaccine doses by December: Sources Ruchika Sharma2 Aug 2022 11:34 AM ISTCervical cancer in India ranks as the second most frequent cancer among women aged between 15 and 44 years.
NTAGI panel reviews data for Biological E Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma22 July 2022 3:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Corbevax, is currently being used to inoculate children in the age group of 12 to 14...
NTAGI to discuss data of Gennova Pharma mRNA vaccine against COVID Ruchika Sharma12 July 2022 1:00 PM ISTThe indigenous innovative mRNA vaccine is based on the second wave driven by the Delta variant and can be kept under 2 to 8 degrees Celsius this means...
DCGI recommends allowing Serum Institute to manufacture, stockpile QHPV vaccine Rahul Verma8 July 2022 5:30 PM ISTThe Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV vaccine...
DCGI recommends allowing SII to manufacture, stockpile life-saving qHPV vaccine against cervical cancer Ruchika Sharma7 July 2022 1:30 PM ISTCervical cancer is the second-most frequent type of the disease in India among women aged between 15 and 44 years.
Include Cy-Tb injection in national TB elimination programme: SII urges MoHFW Ruchika Sharma5 July 2022 1:21 PM ISTNew Delhi: Serum Institute has requested the Union health ministry for inclusion of their Cy-Tb injection for detection of Latent-TB in the National...
Biocon engages law firm for governance review after CBI arrests Ruchika Sharma1 July 2022 2:30 PM ISTNew Delhi: Drugmaker Biocon Ltd. has engaged an external law firm to do a comprehensive review of its governance processes involving consultants and...
